The Latin America, Middle East and Africa Companion Animal Arthritis Market is expected to witness market growth of 8.1% CAGR during the forecast period (2022-2028).
There are numerous ways to treat arthritis in companion animals. Due to their reduced mobility and expectation of experiencing pain if they fall, animals with arthritis or joint pain may be afraid to walk on slick surfaces, like hardwood or tile. On slick flooring, using nonslip rugs, mats, and carpets can enable the animals to move around the house more freely without worrying about slipping. By minimizing the strain on their joints, nonslip rugs should be placed at the bottom and top of stairs, as well as close to couches and beds, to help reduce animal joint pain.
There are several procedures and items on the market to treat joint pain, and each one has supporters and detractors. One thing that all experts agree on is the need for multimodal arthritis management, which simply means that many different approaches should be used concurrently. This includes not only a variety of medications and dietary supplements but also other strategies like weight loss as well as physical therapy. Medications, include glucosamine, chondroitin sulfate, creatine, MSM, non-steroidal anti-inflammatory drugs of the new piprant class, Cox-preferential NSAIDs, as well as cox-selective NSAIDs.
Significant numbers of livestock are present in this region. Many people make their living working in animal husbandry. In 2016, there were 2.3 million families working in South Africa's agricultural sector, according to data provided by Statistics South Africa in their report, Agricultural Households. One source of income for 28% of these people was raising chickens. Because of this, there are more chickens and hens in this area. Additionally, 34.1% engaged in agriculture in the Eastern Cape raised 1 to 10 cattle in 2016. As a result, the number of cattle in this area bolstered dramatically.
The Brazil market dominated the LAMEA Companion Animal Arthritis Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $63.2 million by 2028. The Argentina market is experiencing a CAGR of 8.7% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 7.9% during (2022 - 2028).
Based on Indication, the market is segmented into Osteoarthritis and Other Arthritis. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Stores and Others. Based on Treatment, the market is segmented into Medication, Supplements and Other Treatment. Based on Animal Type, the market is segmented into Dogs, Cats and Other. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health, Inc., Zoetis, Inc., Vetoquinol SA, Virbac, Ceva Santé Animale, Eltech K-Laser s.r.l., Norbrook Laboratories Limited, and NexGen Pharmaceuticals, LLC.
There are numerous ways to treat arthritis in companion animals. Due to their reduced mobility and expectation of experiencing pain if they fall, animals with arthritis or joint pain may be afraid to walk on slick surfaces, like hardwood or tile. On slick flooring, using nonslip rugs, mats, and carpets can enable the animals to move around the house more freely without worrying about slipping. By minimizing the strain on their joints, nonslip rugs should be placed at the bottom and top of stairs, as well as close to couches and beds, to help reduce animal joint pain.
There are several procedures and items on the market to treat joint pain, and each one has supporters and detractors. One thing that all experts agree on is the need for multimodal arthritis management, which simply means that many different approaches should be used concurrently. This includes not only a variety of medications and dietary supplements but also other strategies like weight loss as well as physical therapy. Medications, include glucosamine, chondroitin sulfate, creatine, MSM, non-steroidal anti-inflammatory drugs of the new piprant class, Cox-preferential NSAIDs, as well as cox-selective NSAIDs.
Significant numbers of livestock are present in this region. Many people make their living working in animal husbandry. In 2016, there were 2.3 million families working in South Africa's agricultural sector, according to data provided by Statistics South Africa in their report, Agricultural Households. One source of income for 28% of these people was raising chickens. Because of this, there are more chickens and hens in this area. Additionally, 34.1% engaged in agriculture in the Eastern Cape raised 1 to 10 cattle in 2016. As a result, the number of cattle in this area bolstered dramatically.
The Brazil market dominated the LAMEA Companion Animal Arthritis Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $63.2 million by 2028. The Argentina market is experiencing a CAGR of 8.7% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 7.9% during (2022 - 2028).
Based on Indication, the market is segmented into Osteoarthritis and Other Arthritis. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Stores and Others. Based on Treatment, the market is segmented into Medication, Supplements and Other Treatment. Based on Animal Type, the market is segmented into Dogs, Cats and Other. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health, Inc., Zoetis, Inc., Vetoquinol SA, Virbac, Ceva Santé Animale, Eltech K-Laser s.r.l., Norbrook Laboratories Limited, and NexGen Pharmaceuticals, LLC.
Scope of the Study
Market Segments Covered in the Report:
By Indication
- Osteoarthritis
- Other Arthritis
By Distribution Channel
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- Online Stores
- Others
By Treatment
- Medication
- Supplements
- Other Treatment
By Animal Type
- Dogs
- Cats
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals PLC
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Vetoquinol SA
- Virbac
- Ceva Santé Animale
- Eltech K-Laser s.r.l.
- Norbrook Laboratories Limited
- NexGen Pharmaceuticals, LLC
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Companion Animal Arthritis Market by Indication
Chapter 4. LAMEA Companion Animal Arthritis Market by Distribution Channel
Chapter 5. LAMEA Companion Animal Arthritis Market by Treatment
Chapter 6. LAMEA Companion Animal Arthritis Market by Animal Type
Chapter 7. LAMEA Companion Animal Arthritis Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals PLC
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Vetoquinol SA
- Virbac
- Ceva Santé Animale
- Eltech K-Laser s.r.l.
- Norbrook Laboratories Limited
- NexGen Pharmaceuticals, LLC
Methodology
LOADING...
